These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain. Cuevas MT; Muñoz-Nieto M; Thomson MM; Delgado E; Iribarren JA; Cilla G; Fernández-García A; Santamaría JM; Lezaun MJ; Jiménez L; López-Soria LM; Sota M; Contreras G; Nájera R; Pérez-Alvarez L; J Acquir Immune Defic Syndr; 2009 May; 51(1):99-103. PubMed ID: 19282784 [TBL] [Abstract][Full Text] [Related]
3. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations. Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L; PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil. Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362 [TBL] [Abstract][Full Text] [Related]
5. High Prevalence of Sequences Included in Transmission Clusters Within Newly Diagnosed HIV-1 Patients in Southern Spain (2004-2015). González-Domenech CM; Sena-Corrales G; Viciana-Ramos I; Palacios-Muñoz R; Mora-Navas L; Clavijo-Frutos E; Santos-González J Microb Drug Resist; 2020 Sep; 26(9):1090-1097. PubMed ID: 32240038 [TBL] [Abstract][Full Text] [Related]
6. Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain. Patiño-Galindo JÁ; Torres-Puente M; Bracho MA; Alastrué I; Juan A; Navarro D; Galindo MJ; Gimeno C; Ortega E; González-Candelas F PLoS One; 2017; 12(2):e0171062. PubMed ID: 28152089 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation. Grgic I; Lepej SZ; Lunar MM; Poljak M; Vince A; Vrakela IB; Planinic A; Seme K; Begovac J AIDS Res Hum Retroviruses; 2013 Feb; 29(2):329-36. PubMed ID: 22906365 [TBL] [Abstract][Full Text] [Related]
8. Sexual intermingling of Arab and Jewish MSM in Israel: results of a molecular epidemiology study. Zuckerman NS; Mor Z; Bucris E; Wax M; Mendelson E; Mor O AIDS; 2019 Feb; 33(2):339-344. PubMed ID: 30325775 [TBL] [Abstract][Full Text] [Related]
9. Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranhão State, northeast Brazil. Moura ME; Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM AIDS Res Hum Retroviruses; 2015 Feb; 31(2):250-4. PubMed ID: 25411830 [TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of HIV-1 in Iceland: Early introductions, transmission dynamics and recent outbreaks among injection drug users. Sallam M; Esbjörnsson J; Baldvinsdóttir G; Indriðason H; Björnsdóttir TB; Widell A; Gottfreðsson M; Löve A; Medstrand P Infect Genet Evol; 2017 Apr; 49():157-163. PubMed ID: 28082188 [TBL] [Abstract][Full Text] [Related]
11. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype. Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Maciejewska K; Rymer W; Szymczak A; Szetela B; Gąsiorowski J; Bociąga-Jasik M; Skwara P; Garlicki A; Grzeszczuk A; Rogalska M; Jankowska M; Lemańska M; Hlebowicz M; Barałkiewicz G; Mozer-Lisewska I; Mazurek R; Lojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Clark J; Urbańska A J Antimicrob Chemother; 2015 Jan; 70(1):233-42. PubMed ID: 25248322 [TBL] [Abstract][Full Text] [Related]
12. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance. Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R; Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705 [TBL] [Abstract][Full Text] [Related]
13. The molecular epidemiology of HIV-1 in the Comunidad Valenciana (Spain): analysis of transmission clusters. Patiño-Galindo JÁ; Torres-Puente M; Bracho MA; Alastrué I; Juan A; Navarro D; Galindo MJ; Ocete D; Ortega E; Gimeno C; Belda J; Domínguez V; Moreno R; González-Candelas F Sci Rep; 2017 Sep; 7(1):11584. PubMed ID: 28912478 [TBL] [Abstract][Full Text] [Related]
14. Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe. Delgado E; Cuevas MT; Domínguez F; Vega Y; Cabello M; Fernández-García A; Pérez-Losada M; Castro MÁ; Montero V; Sánchez M; Mariño A; Álvarez H; Ordóñez P; Ocampo A; Miralles C; Pérez-Castro S; López-Álvarez MJ; Rodríguez R; Trigo M; Diz-Arén J; Hinojosa C; Bachiller P; Hernáez-Crespo S; Cisterna R; Garduño E; Pérez-Álvarez L; Thomson MM PLoS One; 2015; 10(11):e0143325. PubMed ID: 26599410 [TBL] [Abstract][Full Text] [Related]
15. Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006. Ibe S; Hattori J; Fujisaki S; Shigemi U; Fujisaki S; Shimizu K; Nakamura K; Kazumi T; Yokomaku Y; Mamiya N; Hamaguchi M; Kaneda T AIDS Res Hum Retroviruses; 2008 Jan; 24(1):7-14. PubMed ID: 18275342 [TBL] [Abstract][Full Text] [Related]
16. Detection of human immunodeficiency virus Type 1 phylogenetic clusters with multidrug resistance mutations among 2011 to 2017 blood donors from the highly endemic Northern Brazilian Amazon. Esashika Crispim MA; da Guarda Reis MN; Fraiji N; Bello G; Stefani MMA Transfusion; 2019 Aug; 59(8):2593-2601. PubMed ID: 31119759 [TBL] [Abstract][Full Text] [Related]
17. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14. Fabeni L; Alteri C; Di Carlo D; Orchi N; Carioti L; Bertoli A; Gori C; Forbici F; Continenza F; Maffongelli G; Pinnetti C; Vergori A; Mondi A; Ammassari A; Borghi V; Giuliani M; De Carli G; Pittalis S; Grisetti S; Pennica A; Mastroianni CM; Montella F; Cristaudo A; Mussini C; Girardi E; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM; ; J Antimicrob Chemother; 2017 Oct; 72(10):2837-2845. PubMed ID: 29091206 [TBL] [Abstract][Full Text] [Related]
18. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations. de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study. Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M; Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623 [TBL] [Abstract][Full Text] [Related]
20. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China. Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]